Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
or

S&P 500 Healthcare Sector SPDR (XLV)

S&P 500 Healthcare Sector SPDR (XLV)
137.30 x 1,500 138.80 x 100
Post-market by (Cboe BZX)
138.05 +0.66 (+0.48%) 04/25/25 [NYSE Arca]
137.30 x 1,500 138.80 x 100
Post-market 138.05 unch (unch) 16:27 ET
Quote Overview for Fri, Apr 25th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
135.88
Day High
138.20
Open 137.59
Previous Close 137.39 137.39
Volume 6,438,400 6,438,400
Avg Vol 12,660,890 12,660,890
Stochastic %K 63.01% 63.01%
Weighted Alpha -4.80 -4.80
5-Day Change +2.56 (+1.89%) +2.56 (+1.89%)
52-Week Range 129.66 - 159.64 129.66 - 159.64
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Price/Earnings ttm 16.67
  • Annual Dividend & Yield 2.34 (1.70%)
  • Most Recent Dividend 0.565 on 03/24/25
  • Management Fee 0.08%
  • INDUSTRY GROUPING:

    ETFs - Biotech

Options Overview Details

View History
  • Implied Volatility 14.93% ( -4.10%)
  • Historical Volatility 26.61%
  • IV Percentile 66%
  • IV Rank 19.40%
  • IV High 41.48% on 04/07/25
  • IV Low 8.55% on 08/30/24
  • Put/Call Vol Ratio 1.82
  • Today's Volume 7,508
  • Volume Avg (30-Day) 17,872
  • Put/Call OI Ratio 1.52
  • Today's Open Interest 376,741
  • Open Int (30-Day) 381,032

Price Performance

See More
Period Period Low Period High Performance
1-Month
129.66 +6.47%
on 04/07/25
Period Open: 145.27
146.62 -5.85%
on 03/31/25
-7.22 (-4.97%)
since 03/25/25
3-Month
129.66 +6.47%
on 04/07/25
Period Open: 144.31
150.32 -8.16%
on 03/03/25
-6.26 (-4.34%)
since 01/24/25
52-Week
129.66 +6.47%
on 04/07/25
Period Open: 139.92
159.64 -13.52%
on 09/04/24
-1.87 (-1.34%)
since 04/25/24

Most Recent Stories

More News
Earnings Preview: What To Expect From Cencora's Report

Cencora is scheduled to report its second-quarter results next month, with analysts projecting a single-digit earnings growth.

XLV : 138.05 (+0.48%)
$SPX : 5,525.21 (+0.74%)
COR : 285.90 (+1.24%)
Bio-Techne's Q3 2025 Earnings: What to Expect

Bio-Techne is scheduled to release its fiscal third-quarter earnings next month, and analysts project a low single-digit bottom-line rise.

TECH : 50.24 (-1.06%)
XLV : 138.05 (+0.48%)
$SPX : 5,525.21 (+0.74%)
Earnings Preview: What to Expect From IDEXX Laboratories' Report

IDEXX Laboratories will release its first-quarter earnings next month, and analysts anticipate a single-digit bottom-line growth.

XLV : 138.05 (+0.48%)
$SPX : 5,525.21 (+0.74%)
IDXX : 437.44 (-0.80%)
CVS Health Earnings Preview: What to Expect

CVS Health is scheduled to report its first-quarter results next month, and analysts expect a double-digit earnings growth.

CVS : 65.32 (-0.91%)
XLV : 138.05 (+0.48%)
$SPX : 5,525.21 (+0.74%)
Here's What to Expect From McKesson's Next Earnings Report

McKesson is expected to release its fiscal fourth-quarter earnings next month, and analysts project a double-digit profit growth.

XLV : 138.05 (+0.48%)
MCK : 695.00 (+0.95%)
$SPX : 5,525.21 (+0.74%)
Earnings Preview: What To Expect From Zoetis’ Report

Zoetis is set to announce its first-quarter results in the upcoming month, and analysts expect a modest single-digit growth in earnings.

XLV : 138.05 (+0.48%)
$SPX : 5,525.21 (+0.74%)
ZTS : 153.47 (+0.77%)
What to Expect From Waters’ Q1 2025 Earnings Report

Waters is gearing up to announce its first-quarter results in the upcoming month, and analysts expect a marginal increase in earnings.

XLV : 138.05 (+0.48%)
$SPX : 5,525.21 (+0.74%)
WAT : 337.89 (-0.82%)
Revvity’s Quarterly Earnings Preview: What You Need to Know

Revvity is gearing up to announce its first-quarter results later this month, and analysts expect a single-digit drop in earnings.

XLV : 138.05 (+0.48%)
$SPX : 5,525.21 (+0.74%)
RVTY : 94.29 (-0.88%)
Henry Schein's Q1 2025 Earnings: What to Expect

Henry Schein is gearing up to announce its Q1 results in the upcoming month, and analysts expect a modest increase in earnings.

XLV : 138.05 (+0.48%)
HSIC : 65.17 (-1.60%)
HSIC : 65.17 (-1.60%)
$SPX : 5,525.21 (+0.74%)
Vertex Pharmaceuticals’ Q1 2025 Earnings: What to Expect

Vertex Pharmaceuticals is set to unveil its Q1 results in the upcoming month, and analysts expect a double-digit drop in earnings.

XLV : 138.05 (+0.48%)
$SPX : 5,525.21 (+0.74%)
VRTX : 493.84 (+0.28%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The Health Care Select Sector SPDR Fund seeks to provide investment results that, before expenses, correspond generally to the price and yield performance of the Health Care Select Sector Index.

See More

Key Turning Points

3rd Resistance Point 141.19
2nd Resistance Point 139.70
1st Resistance Point 138.87
Last Price 138.05
1st Support Level 136.55
2nd Support Level 135.06
3rd Support Level 134.23

See More

52-Week High 159.64
Fibonacci 61.8% 148.19
Fibonacci 50% 144.65
Fibonacci 38.2% 141.11
Last Price 138.05
52-Week Low 129.66

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective